SARC appoints Chief Scientific Officer

SARC is pleased to announce that Dr. Jonathan Fletcher has been appointed Chief Scientific Officer. Dr. Fletcher is a lab-based medical and pediatric oncologist at Harvard Medical School, Brigham and Women’s Hospital, and Dana-Farber Cancer Institute. Dr. Fletcher also serves on the SARC Board of Directors (since February, 2018). Click here to view Dr. Fletcher’s full bio.

Download the News Release.